| http://www.w3.org/ns/prov#value | - on of the blood-brain-barrier or because of decreased cognitive reserve due to chronicbrain HIV infection or comorbidities such as age or vascular disease.On a practical basis, our data support the contention that ARV regimens with estimated goodCNS penetration are more effective than regimens with poorer CNS penetration in controllingCSF (and presumably CNS) viral replication, regardless of the n
|
